Cargando…
Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
Cholesterol is an essential substance in mammalian cells, and cholesterol metabolism plays crucial roles in multiple biological functions. Dysregulated cholesterol metabolism is a metabolic hallmark in several cancers, beyond the Warburg effect. Reprogrammed cholesterol metabolism has been reported...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606538/ https://www.ncbi.nlm.nih.gov/pubmed/34820325 http://dx.doi.org/10.3389/fonc.2021.738177 |
_version_ | 1784602353421254656 |
---|---|
author | He, Jiangnan Siu, Michelle K.Y. Ngan, Hextan Y. S. Chan, Karen K. L. |
author_facet | He, Jiangnan Siu, Michelle K.Y. Ngan, Hextan Y. S. Chan, Karen K. L. |
author_sort | He, Jiangnan |
collection | PubMed |
description | Cholesterol is an essential substance in mammalian cells, and cholesterol metabolism plays crucial roles in multiple biological functions. Dysregulated cholesterol metabolism is a metabolic hallmark in several cancers, beyond the Warburg effect. Reprogrammed cholesterol metabolism has been reported to enhance tumorigenesis, metastasis and chemoresistance in multiple cancer types, including ovarian cancer. Ovarian cancer is one of the most aggressive malignancies worldwide. Alterations in metabolic pathways are characteristic features of ovarian cancer; however, the specific role of cholesterol metabolism remains to be established. In this report, we provide an overview of the key proteins involved in cholesterol metabolism in ovarian cancer, including the rate-limiting enzymes in cholesterol biosynthesis, and the proteins involved in cholesterol uptake, storage and trafficking. Also, we review the roles of cholesterol and its derivatives in ovarian cancer and the tumor microenvironment, and discuss promising related therapeutic targets for ovarian cancer. |
format | Online Article Text |
id | pubmed-8606538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86065382021-11-23 Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets He, Jiangnan Siu, Michelle K.Y. Ngan, Hextan Y. S. Chan, Karen K. L. Front Oncol Oncology Cholesterol is an essential substance in mammalian cells, and cholesterol metabolism plays crucial roles in multiple biological functions. Dysregulated cholesterol metabolism is a metabolic hallmark in several cancers, beyond the Warburg effect. Reprogrammed cholesterol metabolism has been reported to enhance tumorigenesis, metastasis and chemoresistance in multiple cancer types, including ovarian cancer. Ovarian cancer is one of the most aggressive malignancies worldwide. Alterations in metabolic pathways are characteristic features of ovarian cancer; however, the specific role of cholesterol metabolism remains to be established. In this report, we provide an overview of the key proteins involved in cholesterol metabolism in ovarian cancer, including the rate-limiting enzymes in cholesterol biosynthesis, and the proteins involved in cholesterol uptake, storage and trafficking. Also, we review the roles of cholesterol and its derivatives in ovarian cancer and the tumor microenvironment, and discuss promising related therapeutic targets for ovarian cancer. Frontiers Media S.A. 2021-11-08 /pmc/articles/PMC8606538/ /pubmed/34820325 http://dx.doi.org/10.3389/fonc.2021.738177 Text en Copyright © 2021 He, Siu, Ngan and Chan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology He, Jiangnan Siu, Michelle K.Y. Ngan, Hextan Y. S. Chan, Karen K. L. Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets |
title | Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets |
title_full | Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets |
title_fullStr | Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets |
title_full_unstemmed | Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets |
title_short | Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets |
title_sort | aberrant cholesterol metabolism in ovarian cancer: identification of novel therapeutic targets |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606538/ https://www.ncbi.nlm.nih.gov/pubmed/34820325 http://dx.doi.org/10.3389/fonc.2021.738177 |
work_keys_str_mv | AT hejiangnan aberrantcholesterolmetabolisminovariancanceridentificationofnoveltherapeutictargets AT siumichelleky aberrantcholesterolmetabolisminovariancanceridentificationofnoveltherapeutictargets AT nganhextanys aberrantcholesterolmetabolisminovariancanceridentificationofnoveltherapeutictargets AT chankarenkl aberrantcholesterolmetabolisminovariancanceridentificationofnoveltherapeutictargets |